Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 25

1.

Anxiety worsens prognosis in patients with coronary artery disease.

Shibeshi WA, Young-Xu Y, Blatt CM.

J Am Coll Cardiol. 2007 May 22;49(20):2021-7. Epub 2007 May 4.

2.

Long-term outcomes of optimized medical management of outpatients with stable coronary artery disease.

Jabbour S, Young-Xu Y, Graboys TB, Blatt CM, Goldberg RJ, Bedell SE, Bilchik BZ, Lown B, Ravid S.

Am J Cardiol. 2004 Feb 1;93(3):294-9.

PMID:
14759377
3.

Usefulness of statin drugs in protecting against atrial fibrillation in patients with coronary artery disease.

Young-Xu Y, Jabbour S, Goldberg R, Blatt CM, Graboys T, Bilchik B, Ravid S.

Am J Cardiol. 2003 Dec 15;92(12):1379-83.

PMID:
14675569
4.

Long-term statin use and psychological well-being.

Young-Xu Y, Chan KA, Liao JK, Ravid S, Blatt CM.

J Am Coll Cardiol. 2003 Aug 20;42(4):690-7.

5.

Exercise performance-based outcomes of medically treated patients with coronary artery disease and profound ST segment depression.

Thompson CA, Jabbour S, Goldberg RJ, McClean RY, Bilchik BZ, Blatt CM, Ravid S, Graboys TB.

J Am Coll Cardiol. 2000 Dec;36(7):2140-5.

6.

Is exercise testing safe in patients treated with flecainide for atrial arrhythmia?

Blatt CM, Lampert S, Graboys TB.

Am Heart J. 1993 Jul;126(1):268-9. No abstract available.

PMID:
8322688
7.

Results of a second-opinion trial among patients recommended for coronary angiography.

Graboys TB, Biegelsen B, Lampert S, Blatt CM, Lown B.

JAMA. 1992 Nov 11;268(18):2537-40.

PMID:
1404821
8.

The effect of caffeine on ventricular ectopic activity in patients with malignant ventricular arrhythmia.

Graboys TB, Blatt CM, Lown B.

Arch Intern Med. 1989 Mar;149(3):637-9.

PMID:
2465748
9.

Determinants of survival in patients with malignant ventricular arrhythmia associated with coronary artery disease.

Lampert S, Lown B, Graboys TB, Podrid PJ, Blatt CM.

Am J Cardiol. 1988 Apr 1;61(10):791-7.

PMID:
3354443
10.

Noninvasive predictors of sudden cardiac death in patients with coronary artery disease.

Lampert S, Lown B, Graboys TB, Blatt CM.

J Electrocardiol. 1988;21 Suppl:S36-9. No abstract available.

PMID:
3216175
11.

Results of a second-opinion program for coronary artery bypass graft surgery.

Graboys TB, Headley A, Lown B, Lampert S, Blatt CM.

JAMA. 1987 Sep 25;258(12):1611-4.

PMID:
3498051
12.

Aggravation of arrhythmia by antiarrhythmic drugs--incidence and predictors.

Podrid PJ, Lampert S, Graboys TB, Blatt CM, Lown B.

Am J Cardiol. 1987 Apr 30;59(11):38E-44E.

PMID:
2437788
13.

Signal averaging technique for noninvasive recording of late potentials in patients with coronary artery disease.

Abboud S, Blatt CM, Lown B, Graboys TB, Sadeh D, Cohen RJ.

Comput Cardiol. 1987;13:525-8.

PMID:
11541830
14.
15.

Historic perspectives--electrical stimulation of the heart.

Lown B, Graboys TB, Podrid PJ, Lampert S, Blatt CM.

Circulation. 1986 Feb;73(2 Pt 2):II3-10. Review. No abstract available.

PMID:
3510766
16.

Digitalis glycosides: mechanisms and manifestations of toxicity. Part III.

Smith TW, Antman EM, Friedman PL, Blatt CM, Marsh JD.

Prog Cardiovasc Dis. 1984 Jul-Aug;27(1):21-56. Review. No abstract available.

PMID:
6146162
17.

Digitalis glycosides: mechanisms and manifestations of toxicity. Part II.

Smith TW, Antman EM, Friedman PL, Blatt CM, Marsh JD.

Prog Cardiovasc Dis. 1984 May-Jun;26(6):495-540. Review. No abstract available.

PMID:
6326196
18.

Sudden cardiac death--an approach to management of the patient at risk.

Podrid PJ, Blatt CM.

Herz. 1984 Apr;9(2):65-76.

PMID:
6714916
19.

Digitalis glycosides: mechanisms and manifestations of toxicity. Part I.

Smith TW, Antman EM, Friedman PL, Blatt CM, Marsh JD.

Prog Cardiovasc Dis. 1984 Mar-Apr;26(5):413-58. Review. No abstract available.

PMID:
6371896

Supplemental Content

Loading ...
Support Center